0000098362-26-000012
SEC filingThe Timken Company reported net sales of $4.58 billion for the fiscal year ended December 31, 2025, resulting in operating income of $540.6 million and a net income attributable to The Timken Company of $288.4 million. The company achieved a solid operating margin of 11.8% despite facing headwinds including $25.3 million in impairment and restructuring charges and $79.1 million in amortization of intangible assets. Interest expense remained a significant factor at $110.3 million, impacting the bottom line. From a liquidity perspective, Timken generated robust net cash provided by operating activities of $554.3 million, supporting capital expenditures of $148.2 million and resulting in a strong free cash flow position. The company returned $98.3 million to shareholders through dividends and repurchased $57.4 million of treasury shares. The balance sheet reflects total assets of $6.68 billion against total liabilities and equity of $6.68 billion, with a total debt position comprising $38.9 million in short-term debt and $1.88 billion in long-term debt.
For the fiscal year ended December 31, 2025, The Timken Company reported net sales of $4.58 billion. The cost of products sold was $3.19 billion, resulting in a gross profit of $1.39 billion. Operating income was reported at $540.6 million, reflecting the impact of $748.3 million in selling, general and administrative expenses, $79.1 million in amortization of intangible assets, and $25.3 million in impairment and restructuring charges. After accounting for $110.3 million in interest expense and other non-operating items, income before income taxes stood at $416.0 million. The provision for income taxes was $98.7 million, leading to a net income of $317.3 million. Net income attributable to The Timken Company was $288.4 million, with $28.9 million attributable to noncontrolling interests. Diluted earnings per share were $4.00.
The XBRL financial data provided discloses total net sales of $4.58 billion for the fiscal year 2025. Detailed segment breakdowns, geographic revenue distribution, or specific growth drivers were not explicitly itemized in the provided financial data sections. Consequently, a granular analysis of revenue contributions by specific business unit or region cannot be constructed from the available source text without inference. The revenue figure represents the aggregate performance of the company's engineered bearings and industrial motion products portfolio.
The company achieved a gross margin of approximately 30.3%, calculated from net sales of $4.58 billion and cost of products sold of $3.19 billion. The operating margin for the period was 11.8%, derived from operating income of $540.6 million relative to net sales. Profitability was impacted by significant amortization charges of $79.1 million and restructuring costs of $25.3 million. Interest expense of $110.3 million also weighed on pre-tax income. The effective tax rate for the period was approximately 23.7%, based on a provision of $98.7 million against pre-tax income of $416.0 million.
Net cash provided by operating activities was $554.3 million. Capital expenditures totaled $148.2 million, resulting in a free cash flow of approximately $406.1 million. Net cash used in investing activities was $148.3 million, while financing activities used $437.1 million, primarily for debt payments ($365.8M) and dividends ($98.3M). The balance sheet shows total assets of $6.68 billion, including cash and cash equivalents of $364.4 million. Total current assets were $2.60 billion. Long-term debt stood at $1.88 billion, with $38.9 million classified as short-term debt. Total shareholders' equity was $3.18 billion, contributing to total equity of $3.35B.
The provided XBRL financial data and document content do not contain specific forward-looking statements, management guidance, or strategic priorities regarding future fiscal years. Therefore, an outlook section cannot be generated from the explicit source material provided. Investors should refer to the complete 10-K filing for Management's Discussion and Analysis regarding future expectations and risk factors.